Prognostic factors in multiple myeloma

S. V. Rajkumar, P. R. Greipp

Research output: Contribution to journalArticlepeer-review

102 Scopus citations


There is significant variation in the survival of patients with myeloma. This article reviews the major prognostic factors in myeloma and the evidence supporting their usefulness in clinical practice and research. The factors reviewed include serum beta2-microglobulin, bone marrow plasma cell labeling index, cytogenetics, plasmablastic morphology, and other standard clinical laboratory variables. Novel factors such as bone marrow angiogenesis are also discussed. A combination of independent factors provides greater prognostic information than any one factor alone, and survival data using various combinations of prognostic factors are presented.

Original languageEnglish (US)
Pages (from-to)1295-1314
Number of pages20
JournalHematology/Oncology Clinics of North America
Issue number6
StatePublished - 1999

ASJC Scopus subject areas

  • Hematology
  • Oncology


Dive into the research topics of 'Prognostic factors in multiple myeloma'. Together they form a unique fingerprint.

Cite this